ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Should Enhance Funding Of Centers Program, Porter Says

July 12, 1991

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

June 7, 2002

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

NCI-Approved Clinical Trials

October 27, 2006

In Brief: Schmidt Of Germany UICC President Elect David Korn Appointed New Dean At Stanford

October 19, 1984